Navigation Links
Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients
Date:5/20/2008

ist(TM) should

be used with caution in patients with cardiovascular disorders,

especially coronary insufficiency, cardiac arrythmias, and

hypertension.

Funding for these studies was provided by Dey, L.P., manufacturer and marketer of Perforomist(TM) (formoterol fumarate) Inhalation Solution. Perforomist(TM) Inhalation Solution is the first and only FDA-approved nebulized form of formoterol fumarate. Formoterol fumarate is a rapid and long-acting beta(2)-agonist (LABA) that has been previously available in the U.S. in a dry powder formulation with twenty years of worldwide experience. Nebulizers convert liquid medication into a mist that patients inhale through a mouthpiece or facemask.

"Taken together, these studies expand our understanding of the clinical benefits of Perforomist(TM) Inhalation Solution for the treatment of COPD," said Carolyn Myers, Ph.D., President of Dey, L.P. "Perforomist Inhalation Solution offers physicians a flexible, safe, and highly effective treatment option for COPD -- and many patients may benefit from this new addition to the treatment armamentarium."

About Perforomist(TM) Inhalation Solution

Indication

Perforomist(TM) Inhalation Solution is indicated for the long-term, twice-daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema.

Important Safety Information

Perforomist(TM) Inhalation Solution belongs to a class of medications known as long-acting beta(2)-adrenergic agonists (LABAs). LABAs may increase the risk of asthma-related death. Data from a large placebo-controlled US study comparing the safety of another LABA (salmeterol) or placebo added to usual asthma therapy showed an increase in asthma-related deaths in patients receiving salmeterol. This finding with salmeterol may apply to formoterol (a LABA), the active
'/>"/>

SOURCE Dey, L.P.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone
2. Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD
3. New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease
4. Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
5. Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination
6. Data Show Rufinamide, an Investigational Adjunctive Treatment for Lennox- Gastaut Syndrome, Reduced Drop Attacks by More Than 40%
7. Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib)
8. Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C
9. RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer
10. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
11. Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 25, 2014  At the American Dental Association,s Annual ... October, KaVo Kerr Group was honored to be part ... the opportunity to see and test the Best of ... deliver lectures on the latest developments in dental technology. ... new DEXIS CariVu Caries Detection Device and Kerr Demi ...
(Date:11/26/2014)... Mass. , Nov. 25, 2014 Reinforcing ... Royal Philips (NYSE: PHG AEX: ... and Drug Administration (FDA) for its IQon Spectral ... imaging. This first-of-its kind technology adds a new dimension ... offering the ability to characterize structures based on their ...
(Date:11/26/2014)... , Nov. 25, 2014 Nanomix ... on the development of mobile diagnostic tests ... in hospital and pre-hospital settings, today announced ... 13485:2003 certification.  The certification was awarded by ... the world,s leading certification bodies. ...
Breaking Medicine Technology:KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3Philips receives FDA 510(k) clearance for IQon Spectral CT 2Philips receives FDA 510(k) clearance for IQon Spectral CT 3Nanomix Receives ISO 13485:2003 Certification 2
... 21, 2011 Reportlinker.com announces that a ... its catalogue: Global Micro-Electromechanical ... http://www.reportlinker.com/p0459150/Global-Micro-Electromechanical-Systems-MEMs-Devices-Industry.html This report ... (MEMS) Devices in US$ Million by the ...
... March 21, 2011 Bayer HealthCare Pharmaceuticals was handed ... highly-publicized aspirin is unlikely to relieve.  The law firm ... action complaint in U.S. District Court for New Jersey, ... experiences of female employees at Novartis Pharmaceuticals who successfully ...
Cached Medicine Technology:Reportlinker Adds Global Micro-Electromechanical Systems (MEMs) Devices Industry 2Reportlinker Adds Global Micro-Electromechanical Systems (MEMs) Devices Industry 3Reportlinker Adds Global Micro-Electromechanical Systems (MEMs) Devices Industry 4Reportlinker Adds Global Micro-Electromechanical Systems (MEMs) Devices Industry 5Reportlinker Adds Global Micro-Electromechanical Systems (MEMs) Devices Industry 6Reportlinker Adds Global Micro-Electromechanical Systems (MEMs) Devices Industry 7Reportlinker Adds Global Micro-Electromechanical Systems (MEMs) Devices Industry 8Reportlinker Adds Global Micro-Electromechanical Systems (MEMs) Devices Industry 9Reportlinker Adds Global Micro-Electromechanical Systems (MEMs) Devices Industry 10Reportlinker Adds Global Micro-Electromechanical Systems (MEMs) Devices Industry 11Reportlinker Adds Global Micro-Electromechanical Systems (MEMs) Devices Industry 12Reportlinker Adds Global Micro-Electromechanical Systems (MEMs) Devices Industry 13Reportlinker Adds Global Micro-Electromechanical Systems (MEMs) Devices Industry 14Reportlinker Adds Global Micro-Electromechanical Systems (MEMs) Devices Industry 15Reportlinker Adds Global Micro-Electromechanical Systems (MEMs) Devices Industry 16Reportlinker Adds Global Micro-Electromechanical Systems (MEMs) Devices Industry 17Reportlinker Adds Global Micro-Electromechanical Systems (MEMs) Devices Industry 18Reportlinker Adds Global Micro-Electromechanical Systems (MEMs) Devices Industry 19Reportlinker Adds Global Micro-Electromechanical Systems (MEMs) Devices Industry 20Reportlinker Adds Global Micro-Electromechanical Systems (MEMs) Devices Industry 21Reportlinker Adds Global Micro-Electromechanical Systems (MEMs) Devices Industry 22Reportlinker Adds Global Micro-Electromechanical Systems (MEMs) Devices Industry 23Reportlinker Adds Global Micro-Electromechanical Systems (MEMs) Devices Industry 24Bayer Gets $100M Gender Class Action Headache 2Bayer Gets $100M Gender Class Action Headache 3Bayer Gets $100M Gender Class Action Headache 4
(Date:11/26/2014)... (PRWEB) November 26, 2014 The city ... water shortages, is moving forward with a plan to ... water.* Radio host Sharon Kleyne supports the San Diego ... Water Management” (TWM). According to Kleyne, by recycling water ... import new water could be greatly reduced. (Spagat, E, ...
(Date:11/26/2014)... California (PRWEB) November 26, 2014 GI ... never before seen reductions in prices of their popular ... Liposomal Vitamin D3 . Discounts of 40% ... , GI for Life’s proprietary ColoVite supplement is ... gastroenterologists to promote colon health. One easy-to-take colon vitamin ...
(Date:11/26/2014)... November 26, 2014 Call 866-997-4948 (Us-Canada ... or email the details on sales(at)researchmoz(dot)us , Researchmoz.us ... drug discovery market 2014" with deep study of the ... result of high blood sugar. The global glucose monitoring ... to the growing number of diabetics in the world. ...
(Date:11/26/2014)... Lenexa, Kansas (PRWEB) November 26, 2014 ... will showcase expanded capabilities at RSNA 2014 ... capture, access, manage and share diagnostic images, photos, ... Visitors to Perceptive’s booth #8107 will learn more ... including newly acquired technologies and partner initiatives – ...
(Date:11/26/2014)... 2014 (HealthDay News) -- Teens prescribed anti-anxiety or ... those drugs than other teens, a new study ... conduct substance abuse assessments on teenagers before prescribing ... "Prescribers and parents don,t realize the abuse potential," ... the University of Michigan School of Nursing. "These ...
Breaking Medicine News(10 mins):Health News:Global fresh water advocate supports San Diego wastewater recycling plan 2Health News:Global fresh water advocate supports San Diego wastewater recycling plan 3Health News:GI For Life Slashes Prices by 40% on Liposomal Vitamin D3 and ColoVite Colon Health Formula for a Limited Time 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 3Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2
... , MCLEAN, Va., Oct. 19 Sunrise Senior Living, Inc. ... into a 13(th) Amendment to its credit agreement with its ... to December 2, 2010. , "This full-year extension of ... said Mark Ordan, Sunrise,s chief executive officer. "All of our ...
... , DURHAM, N.C., Oct. 19 Oxygen Biotherapeutics, Inc. (OTC ... reverse stock split. The vote was part of a general ... management,s nominees to the company board of directors. , At ... for the formal launch of the company,s Dermacyte(TM) Oxygen Concentrate ...
... , PSAs Offer Vital Information for Adults, Children ... 19 As preparations for the H1N1 flu season ... a statewide public education and media campaign. , The ... public service announcements (PSAs) aimed at educating all Californians ...
... Gehrig,s disease in mice Amyotrophic lateral ... a neurodegenerative disease that causes progressive weakness, disability, and ... mutated form of the human SOD1 gene that causes ... at the University of Rochester Medical Center, Rochester, have ...
... treatment cuts rates of illegal activities, researchers say , ... disorder (ADHD) are more likely than other children to ... U.S. study has found. , The study included more ... It found that youngsters with ADHD were twice as ...
... patients daily may be key players in spreading germs ... who see many patients may play a disproportionate role ... , These so-called peripatetic workers, such as radiologists or ... a day, said Laura Temime, a researcher at the ...
Cached Medicine News:Health News:Sunrise Enters into 13th Amendment to Credit Agreement Extending Maturity Date to December 2, 2010 2Health News:Sunrise Enters into 13th Amendment to Credit Agreement Extending Maturity Date to December 2, 2010 3Health News:Sunrise Enters into 13th Amendment to Credit Agreement Extending Maturity Date to December 2, 2010 4Health News:Oxygen Biotherapeutics, Inc. Shareholders Approve Reverse Stock Split 2Health News:Oxygen Biotherapeutics, Inc. Shareholders Approve Reverse Stock Split 3Health News:California Hospitals Launch H1N1 Public Service Announcement Campaign 2Health News:JCI table of contents: Oct. 19, 2009 2Health News:JCI table of contents: Oct. 19, 2009 3Health News:Childhood ADHD Linked to Criminal Behavior in Adults 2Health News:Hospital Workers May Trigger Dangerous Outbreaks 2Health News:Hospital Workers May Trigger Dangerous Outbreaks 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: